摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-2-Vinyl-6-methyltetrahydro-4H-pyran | 82293-67-2

中文名称
——
中文别名
——
英文名称
cis-2-Vinyl-6-methyltetrahydro-4H-pyran
英文别名
cis vinyl-2 methyl-6 tetrahydropyranne;cis-2-vinyl-6-methyltetrahydropyran;cis-2-(vinylmethyl)tetrahydropyran;cis-6-methyl-2-vinyl-tetrahydropyran;(2S,6S)-2-ethenyl-6-methyloxane
cis-2-Vinyl-6-methyltetrahydro-4H-pyran化学式
CAS
82293-67-2
化学式
C8H14O
mdl
——
分子量
126.199
InChiKey
UMYYXAXDBFKPKM-JGVFFNPUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

点击查看最新优质反应信息

文献信息

  • A new reaction in organosilicon chemistry: the oxidative ring closure of allylsilanes with ceric ammonium nitrate
    作者:Stephen R. Wilson、Corinne E. Augelli-Szafran
    DOI:10.1016/s0040-4020(01)86650-3
    日期:1988.1
    Allylsilanes containing heteroatom nucleophiles yield cyclic products when treated with (NH4)2Ce(NO3)6. For example, hydroxy and amido-containing allylsilanes yield the corresponding tetrahydrofuran, tetrahydropyran, and piperidine analogs. These reactions and their application to natural product synthesis will be discussed.
    当用(NH 4)2 Ce(NO 3)6处理时,含有杂原子亲核试剂的烯丙基硅烷会产生环状产物。例如,含羟基和含酰胺基的烯丙基硅烷可产生相应的四氢呋喃,四氢吡喃和哌啶类似物。将讨论这些反应及其在天然产物合成中的应用。
  • The cyclisation of secondary allenic alcohols
    作者:Timothy Gallagher
    DOI:10.1039/c39840001554
    日期:——
    The silver-mediated cyclisation of secondary allenic alcohols is streoselective giving predominantly cis-2,6-disubstituted tetrahydropyrans; this methodology has been applied to the synthesis of the civet constituent (4).
    银介导的仲烯丙醇的环化是立体选择性的,主要产生顺式-2,6-二取代的四氢吡喃;该方法学已经被用于果子狸成分的合成(4)。
  • 1-SUBSTITUTED-7-( -D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME
    申请人:Kissei Pharmaceutical Co., Ltd.
    公开号:EP1849795A1
    公开(公告)日:2007-10-31
    [Objective] The present invention provides a compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity or the like. [Means to Solve the Problem] It is a 1-substituted-7-(β-D-glycopyranosyloxy)(aza)-indole compound represented by the general formula (I), a prodrug thereof, or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof: wherein R1 represents a halogen atom or the like; n represents an integer number from 0 to 3; R2 represents a hydrogen atom or the like; X represents a carbon atom which a hydrogen atom or the like binds to, or a nitrogen atom; Q represents an alkylene group or an alkenylene group each of which may have an oxygen atom or a sulfur atom in the chain; and A represents an aryl or heteroaryl group which may have a substituent.
    目的 本发明提供了一种具有SGLT1和/或SGLT2抑制活性的化合物,该化合物可用作预防或治疗糖尿病、餐后高血糖症、糖耐量受损、糖尿病并发症、肥胖症或类似疾病的药物。 [解决问题的方法] 本发明是一种由通式(I)代表的1-取代-7-(β-D-甘氨酰吡喃氧基)(氮杂)-吲哚化合物、其原药、或其药学上可接受的盐,或其水合物或溶液: 其中 R1 代表卤素原子或类似物;n 代表 0 至 3 的整数;R2 代表氢原子或类似物;X 代表与氢原子或类似物结合的碳原子或氮原子;Q 代表亚烷基或烯基,每个亚烷基或烯基的链中可以有一个氧原子或一个硫原子;A 代表芳基或杂芳基,可以有一个取代基。
  • Carbon-13 NMR spectra of saturated heterocycles: XI—Tetrahydropyrans (oxanes)
    作者:Ernest L. Eliel、Muthiah Manoharan、K. Michal Pietrusiewicz、Karl D. Hargrave
    DOI:10.1002/omr.1270210205
    日期:1983.2
    AbstractThe 13C NMR spectra of 62 oxanes (tetrahydropyrans) with and without methyl substituents at various ring positions, some of them bearing in addition (or instead) ethyl, vinyl, ethynyl, carbomethoxy and methylol substituents at C‐2, have been recorded, and the 294 resulting chemical shifts have been correlated by multiple linear regression analysis. Axial and equatorial α‐, β‐, γ‐, δ‐, gem‐ and vic‐parameters for shifts caused by methyl groups at all ring positions, and similar parameters for Et,—CHCH2,—CCH, CO2Me and CH2OH groups at C‐2, are reported. Standard deviations of the parameters are, in most cases, within 0.3 ppm and the agreement of calculated and experimental shifts is excellent. This is probably the largest parameter set of this type extant. 13C NMR spectra of a number of additional substituted tetrahydropyrans, and of 3,6‐dihydro‐2H‐pyrans and 3,4‐dihydro‐2H‐pyrans, are tabulated and discussed.
  • Conformational analysis. 42. Monosubstituted tetrahydropyrans
    作者:Ernest L. Eliel、Karl D. Hargrave、K. Michal Pietrusiewicz、Muthiah Manoharan
    DOI:10.1021/ja00377a015
    日期:1982.6
查看更多

同类化合物

(3S,4R)-3-氟四氢-2H-吡喃-4-胺 鲁比前列素中间体 顺-4-(四氢吡喃-2-氧)-2-丁烯-1-醇 顺-3-Boc-氨基-四氢吡喃-4-羧酸 锡烷,三丁基[3-[(四氢-2H-吡喃-2-基)氧代]-1-炔丙基]- 蒜味伞醇B 蒜味伞醇A 茉莉吡喃 苄基2,3-二-O-乙酰基-4-脱氧-4-C-硝基亚甲基-β-D-阿拉伯吡喃果糖苷 膜质菊内酯 红没药醇氧化物A 科立内酯 甲磺酸酯-四聚乙二醇-四氢吡喃醚 甲基[(噁烷-3-基)甲基]胺 甲基6-氧杂双环[3.1.0]己烷-2-羧酸酯 甲基4-脱氧吡喃己糖苷 甲基2,4,6-三脱氧-2,4-二-C-甲基吡喃葡己糖苷 甲基1,2-环戊烯环氧物 甲基-[2-吡咯烷-1-基-1-(四氢-吡喃-4-基)-乙基]-胺 甲基-(四氢吡喃-4-甲基)胺 甲基-(四氢吡喃-2-甲基)胺盐酸盐 甲基-(四氢吡喃-2-甲基)胺 甲基-(四氢-吡喃-3-基-胺 甲基-(四氢-吡喃-3-基)-胺盐酸盐 甲基-(4-吡咯烷-1-甲基四氢吡喃-4-基)-胺 甲基(5R)-3,4-二脱氧-4-氟-5-甲基-alpha-D-赤式-吡喃戊糖苷 环氧乙烷-2-醇乙酸酯 环己酮,6-[(丁基硫代)亚甲基]-2,2-二甲基-3-[(四氢-2H-吡喃-2-基)氧代]-,(3S)- 环丙基-(四氢-吡喃-4-基)-胺 玫瑰醚 独一味素B 溴-六聚乙二醇-四氢吡喃醚 氯菊素 氯丹环氧化物 氨甲酸,[[(四氢-2H-吡喃-2-基)氧代]甲基]-,乙基酯 氧化氯丹 正-(四氢-4-苯基-2h-吡喃-4-基)乙酰胺 次甲霉素 A 桉叶油醇 抗-11-氧杂三环[4.3.1.12,5]十一碳-3-烯-10-酮 戊二酸二甲酯 恩洛铂 异丙基-(四氢吡喃-4-基)胺 四氢吡喃醚-二聚乙二醇 四氢吡喃酮 四氢吡喃-4-醇 四氢吡喃-4-肼二盐酸盐 四氢吡喃-4-羧酸甲酯 四氢吡喃-4-羧酸噻吩酯